HIV/AIDS
Epa-Efe/Divyakant Solanki
© Credits
HIV/AIDS

HIV/AIDS in the South-East Asia

The Human Immunodeficiency Virus (HIV) infects cells of the immune system, destroying or impairing their function. This leads to progressive deterioration of the immune system, leading to "Acquired Immune Deficiency Syndrome (AIDS)". The immune deficient system can no longer fulfill its role of fighting infection and person starts getting various "opportunistic infections". In 2018, out of the 37.9 people living with HIV globally, 3.8 million were living in 11 countries of the South-East Asia Region of WHO.

HIV can be transmitted only through four major routes - unprotected vaginal or anal sexual intercourse, transfusion of contaminated blood; and the sharing of contaminated needles, syringes, surgical equipment or other sharp instruments. It may also be transmitted from a mother to her infant during pregnancy, childbirth and breastfeeding.

Antiretroviral (ARV) drugs are used in the treatment and prevention of HIV infection. They fight HIV by stopping or interfering with the reproduction of the virus in the body, reducing the amount of virus in the body. By 2018, 23.3 million people were receiving HIV antiretroviral therapy (ART) globally, of which two million are from countries in the WHO South-East Asia Region.

-

27%

Reduction in AIDS related deaths between 2010-2019 in WHO South-East Asia Region

24%

Reduction in new HIV infection in WHO South-East Asia Region, between 2010-2019

160 000

New infections in WHO SEA Region in 2019, majority of which are from KPs and their partners

60%

People living with HIV in WHO South-East Asia Region were receiving antiretroviral treatment in 2019

2.2 million

People in the WHO South-East Asia Region were receiving antiretroviral treatment by end 2019

3.7 million

People living with HIV in the WHO South-East Asia Region in 2019

Joint Statement: Compulsory drug detention and rehabilitation centres

Summary/Description

UNAIDS, WHO SEARO, WHO WPRO, and other United Nations entities in the region urgently call on Member States to close compulsory drug detention and rehabilitation centres and implement voluntary, evidence-informed and rights-based health and social services in the community.


Key Messages

  1. There is no evidence that compulsory drug detention and rehabilitation centres are beneficial in terms of a favourable or effective environment for the treatment of drug dependence; or for the “rehabilitation” of individuals who have engaged in sex work; or for children who have been victims of sexual exploitation, abuse or the lack of adequate care and protection. Instead, inmates face higher vulnerabilities, including HIV, TB as well as COVID-19, as a result of sub-standard living conditions, including massive overcrowding and other challenges in maintaining physical distancing. 
  2. Compulsory drug detention and rehabilitation centres need to be closed. Instead, voluntary, evidence-informed and rights-based health and social services must be implemented in the community. This is as an important measure to curb the spread of COVID-19 and to facilitate the recovery and reintegration of those in the centres back into their families and communities.
  3. UN entities at the global level have urged political leaders to ensure that COVID-19 preparedness and responses in prisons and any closed settings are identified and implemented in line with fundamental human rights; are guided by WHO guidance and recommendations; and never amount to torture and other cruel, inhuman or degrading treatment or punishment.
  4. WHO SEARO stand committed to work with Member States as they take steps to permanently close compulsory drug detention and rehabilitation centres. WHO will support transition to evidence-informed system of voluntary community-based treatment and services that are aligned with international guidelines and principles of drug dependence treatment, drug use and human rights.

Publications